Featured News
Think Bioscience
raises $17M oversubscribed seed round to develop small molecule drugs that hit un-druggable proteins
August 19, 2022
—
Innosphere
Astronomer
announces $213M Series C financing, reaching unicorn status
March 23, 2022
—
TechCrunch
SPAN
raises $90M to give consumers more control over how their cars and homes are powered
March 22, 2022
—
Bloomberg
Solo AVT
is building the first electric heavy-duty truck platforms designed for autonomous freight
March 16, 2022
—
TechCrunch
Near Space Labs
first to market with 10cm-per-pixel ultra high-resolution earth imagery
February 3, 2022
—
Axios
MycoWorks
raises $125M Series C to scale production of their luxury material "Reishi"
January 13, 2022
—
TechCrunch
Mammoth Biosciences
partners with Bayer Pharma to advance cell and gene therapies with CRISPR, in a deal worth up to $1B
January 10, 2022
—
BioSpace
Phytoform Labs
announces $5.7M financing to develop sustainable & climate-resilient crops using AI and genome-editing
December 16, 2021
—
TechCrunch
Wireframe
welcomes Lily Bernicker as a Principal on the Wireframe investment team
December 9, 2021
—
SPAN
will transform the grid as we know it with Sunrun partnership and new EV charger
October 29, 2021
—
Forbes
All community news
→
menu
Close
About
Team
Portfolio
Community
For our founders
Portal
→
Forum
→
Request Access
→
News
No items found.
Home
/
Community
/
Mammoth Bio Unicorn
September 9, 2021
—
Forbes
—
No items found.
Subscribe to our newsletter
For occasional news & updates from Wireframe Ventures.
Thank you! Your submission has been received!
Something went wrong. Please try again.
By signing up you agree to our
privacy policy
No items found.
Other reads you might enjoy.
View all
October 7, 2020
—
Nobel Committee
Mammoth Bio
Prof. Jennifer Doudna, co-founder of Mammoth Biosciences, awarded the 2020 Nobel Prize in Chemistry
News
March 22, 2021
—
New York Times
Mammoth Bio
"The Code Breaker" is a New York Times #1 Best-seller about CRISPR & Mammoth co-founder Prof. Jennifer Doudna
Founder Stories
June 22, 2021
—
WSJ
Enveda Biosciences
Lux Capital leads $51M Series A financing in Enveda Biosciences to unlock new medicines from nature
News